Insider Transactions in Q2 2022 at Intercept Pharmaceuticals, Inc. (ICPT)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 21
2022
|
Andrew Saik EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,632
-5.82%
|
$43,584
$12.48 P/Share
|
|
Jun 14
2022
|
M Michelle Berrey President, R&D and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,984
-6.44%
|
$59,808
$12.1 P/Share
|
|
May 25
2022
|
Dagmar Rosa Bjorkeson Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,737
+29.74%
|
-
|
|
May 25
2022
|
Keith Michael Gottesdiener Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,737
+23.84%
|
-
|
|
May 25
2022
|
Nancy Miller Rich Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,737
+25.75%
|
-
|
|
May 25
2022
|
Gino Santini Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,737
+24.65%
|
-
|
|
May 25
2022
|
Glenn Sblendorio Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,737
+24.81%
|
-
|
|
May 25
2022
|
Srinivas Akkaraju Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,737
+16.96%
|
-
|
|
May 25
2022
|
Luca Benatti Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,737
+23.29%
|
-
|
|
May 25
2022
|
Daniel Bradbury Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,737
+24.73%
|
-
|
|
May 25
2022
|
Fundaro Paolo Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,737
+17.77%
|
-
|
|
May 15
2022
|
Linda M Richardson EVP & Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
124
-0.37%
|
$2,108
$17.88 P/Share
|
|
May 01
2022
|
Jared Freedberg General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
771
-1.53%
|
$11,565
$15.71 P/Share
|
|
Apr 11
2022
|
Bryan Ball Chief Qual. Officer & SVP Ops. |
SELL
Payment of exercise price or tax liability
|
Direct |
531
-2.03%
|
$9,027
$17.19 P/Share
|